ERA - Leading European Nephrology

My ERA ERA beitreten

Home | Video pages | Webcast | The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

Teilen

https://www.youtube.com/watch?v=pEw5i17BSjY kopieren

Other e-seminars from EuReCa-M

What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

Heart failure in patients with CKD: diagnosis and therapeutic approaches

Calcification propensity: from biomarker to treatment target?

Assessment and management of hypertension in dialysis patients

GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection

Echocardiography or Cardiac Magnetic resonance Imaging (or both) for cardiac assessment in CKD patients?

Physical Activity in CKD patients: time to overcome nephrologist’s inertia

Let´s talk about sex: disparities in the outcomes and quality of care of men and women with kidney disease